Cost-effectiveness Comparison of Ceftazidime/Avibactam Versus Meropenem in the Empirical Treatment of Hospital-acquired Pneumonia, Including Ventilator-associated Pneumonia, in Italy-Reference-Cited by-同舟云学术

Cost-effectiveness Comparison of Ceftazidime/Avibactam Versus Meropenem in the Empirical Treatment of Hospital-acquired Pneumonia, Including Ventilator-associated Pneumonia, in Italy

Published:2020-05 Issue:5 Volume:42 Page:802-817
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Tichy Eszter,Torres Antoni^ORCID,Bassetti Matteo,Kongnakorn Thitima,Di Virgilio Roberto,Irani Paurus,Charbonneau Claudie

Funder

Pfizer

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference35 articles.

1. Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management;Barbier;Curr Opin Pulm Med,2013

2. Current and future considerations for the treatment of hospital-acquired pneumonia;Montravers;Adv Ther,2016

3. Ventilator associated pneumonia;Hunter;Postgrad Med J,2006

4. Guideline-adherent initial intravenous antibiotic therapy for hospital-acquired/ventilator-associated pneumonia is clinically superior, saves lives and is cheaper than non-guideline adherent therapy;Wilke;Eur J Med Res,2011

5. Economic impact of ventilator-associated pneumonia in a large matched cohort;Kollef;Infect Control Hosp Epidemiol,2012

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model;HEALTH TECHNOL ASSES;2024

2. Cost-effectiveness analysis of CTZ/TAZ for the treatment of ventilated hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia in Japan;BMC Health Services Research;2024-03-28

3. Cost-Effectiveness of Short Course of Ceftazidime/Avibactam for K. pneumoniae-KPC Bloodstream Infections in Italy;Microorganisms;2023-04-23

4. A review of economic studies evaluating the treatment of ventilator associated pneumonia;2023-03-27

5. New antibiotics for Gram-negative pneumonia;European Respiratory Review;2022-12-21